Amber Salzman, Ph.D.
Advertisement
Amber Salzman, Ph.D., is the president and CEO of Ohana Biosciences.
Articles by Amber Salzman, Ph.D.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
How the Wegovy Pill Approval Reshapes Solid Dosage Manufacturing Strategy
2
Harnessing Data and Secure Cloud Environments for Global Pharma Solutions
3
Innovation and Market Exclusivity in the EU
4
Orchestrating the Pharmaceutical Future: Living Decision Engines and AI Integration
5